Aditxt (ADTX) Other Non Operating Income (2020 - 2021)
Aditxt (ADTX) recorded quarterly Other Non Operating Income of -$2.5 million in Q3 2021, down 27888.56% quarter-over-quarter from $9000.0 in Q3 2020, and down 27888.56% on a YoY basis from N/an in Q3 2020.
Aditxt (ADTX) Other Non Operating Income (2020 - 2021) Analysis & Trends
Aditxt's Other Non Operating Income history runs 2 years deep, the most recent figure standing at -$2.5 million for Q3 2021.
- In Q3 2021, Other Non Operating Income fell 27888.56% year-over-year to -$2.5 million; the TTM figure through Dec 2021 stood at -$2.5 million (down 7767.6% YoY), while the FY2025 annual figure was $3000.0, changed N/A from the prior year.
- Other Non Operating Income was -$2.5 million for Q3 2021 at Aditxt, down from $9000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $32500.0 in Q1 2020 to a low of -$2.5 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -2.50 Mn |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | -9,000.00 |
| Mar 31, 2020 | 32,500.00 |